Rapid Nexus Nanotech Wound Solutions, Inc.
PrivateLast Round
Seed
Sep 23, 2025
Total Funding Raised
$3.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rapid Nexus Nanotech Wound Solutions, Inc. operates in Healthcare & Life Sciences and is based in Brea, California. Its latest recorded funding round was a Seed round in September 2025.
Rapid Nexus Nanotech Wound Solutions, Inc. is a medical technology company that develops regenerative wound healing solutions, including the Hemastyl gel and Periwound NerveStim device, to treat chronic wounds and prevent amputations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rapid Nexus Nanotech Wound Solutions, Inc. Comparables
Compare Rapid Nexus Nanotech Wound Solutions, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuo Therapeutics Inc | 73% | |
| Imbed Biosciences | 73% | |
| Conexeu Sciences Inc. | 68% |
For institutional investors. Book with your work email.
Rapid Nexus Nanotech Wound Solutions, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 329% MoM.
- Jun 22, 2026
Monthly visitors increased 138% MoM, reaching 347.
For institutional investors. Book with your work email.
Rapid Nexus Nanotech Wound Solutions, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rapid Nexus Nanotech Wound Solutions, Inc.'s valuation, stock price, and market status.
Is Rapid Nexus Nanotech Wound Solutions, Inc. a public or private company?
Rapid Nexus Nanotech Wound Solutions, Inc. is a private company.
What is the current stock price of Rapid Nexus Nanotech Wound Solutions, Inc.?
Rapid Nexus Nanotech Wound Solutions, Inc. is a private company, so its shares have no public market price. Caplight tracks Rapid Nexus Nanotech Wound Solutions, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rapid Nexus Nanotech Wound Solutions, Inc. worth (valuation)?
Valuation information for Rapid Nexus Nanotech Wound Solutions, Inc. is not publicly available.
Can I buy Rapid Nexus Nanotech Wound Solutions, Inc. stock?
Rapid Nexus Nanotech Wound Solutions, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rapid Nexus Nanotech Wound Solutions, Inc.'s last funding round?
Rapid Nexus Nanotech Wound Solutions, Inc.'s most recent funding round was Seed on September 23, 2025.
Who are the main investors in Rapid Nexus Nanotech Wound Solutions, Inc.?
Investor information for Rapid Nexus Nanotech Wound Solutions, Inc. is not publicly disclosed.
Will Rapid Nexus Nanotech Wound Solutions, Inc. IPO soon?
No public IPO plans have been announced for Rapid Nexus Nanotech Wound Solutions, Inc..
How can I track Rapid Nexus Nanotech Wound Solutions, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Rapid Nexus Nanotech Wound Solutions, Inc.'s shares on secondary markets.